TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A.

Brown AL, Wilkins OG, Keuss MJ, Kargbo-Hill SE, Zanovello M, Lee WC, Bampton A, Lee FCY, Masino L, Qi YA, Bryce-Smith S, Gatt A, Hallegger M, Fagegaltier D, Phatnani H, NYGC ALS Consortium, Newcombe J, Gustavsson EK, Seddighi S, Reyes JF, Coon SL, Ramos D, Schiavo G, Fisher EMC, Raj T, Secrier M, Lashley T, Ule J, Buratti E, Humphrey J, Ward ME, Fratta P. · 2022

Read TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. by Brown AL, Wilkins OG, Keuss MJ, Kargbo-Hill SE, Zanovello M, Lee WC, Bampton A, Lee FCY, Masino L, Qi YA, Bryce-Smith S, Gatt A, Hallegger M, Fagegaltier D, Phatnani H, NYGC ALS Consortium, Newcombe J, Gustavsson EK, Seddighi S, Reyes JF, Coon SL, Ramos D, Schiavo G, Fisher EMC, Raj T, Secrier M, Lashley T, Ule J, Buratti E, Humphrey J, Ward ME, Fratta P. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8891020.txt.

Introduction

Brown and co-authors show how ALS risk variants and TDP-43 loss combine to drain a vital synaptic gene. The gene is UNC13A, central to synapse function. Its variants raise risk of ALS and frontotemporal dementia. Both diseases feature TDP-43 leaving the cell nucleus. The team asked what TDP-43 loss does to UNC13A. Depleting TDP-43 triggered heavy cryptic exon inclusion. The faulty RNA was then destroyed. UNC13A protein fell as a result.

Two common variants sit where TDP-43 binds. Both variants strengthen the cryptic splicing. The effect showed in cultured cells. It also showed in patient brains and spinal cords. The authors frame a clear mechanism. Genetic risk magnifies the harm of TDP-43 loss. They offer the pathway as a drug target. It could serve a whole class of TDP-43 diseases.

Catalog record

CREATORBrown AL, Wilkins OG, Keuss MJ, Kargbo-Hill SE, Zanovello M, Lee WC, Bampton A, Lee FCY, Masino L, Qi YA, Bryce-Smith S, Gatt A, Hallegger M, Fagegaltier D, Phatnani H, NYGC ALS Consortium, Newcombe J, Gustavsson EK, Seddighi S, Reyes JF, Coon SL, Ramos D, Schiavo G, Fisher EMC, Raj T, Secrier M, Lashley T, Ule J, Buratti E, Humphrey J, Ward ME, Fratta P.
YEAR2022
COLLECTIONPAPERS
FORMATTXT
FILE SIZE99 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8891020

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A By Anna-Leigh Brown, Oscar G. Wilkins, Matthew J. Keuss, Sarah E. Kargbo-Hill, Matteo Zanovello, Weaverly Colleen Lee, Alexander Bampton, Flora C. Y. Lee, Laura Masino, Yue A. Qi, Sam Bryce-Smith, Ariana Gatt Published in: Nature DOI: 10.1038/s41586-022-04436-3 ABSTRACT Variants of UNC13A, a critical gene for synapse function, increase the risk of amyotrophic lateral sclerosis and frontotemporal dementia1–3, two related neurodegenerative diseases defined by mislocalization of the RNA-binding protein TDP-434,5. Here we show that TDP-43 depletion induces robust inclusion of a cryptic exon in UNC13A, resulting in nonsense-mediated decay and loss of UNC13A protein. Two common intronic UNC13A polymorphisms strongly associated with amyotrophic lateral sclerosis and frontotemporal dementia risk overlap with TDP-43 binding sites. These polymorphisms potentiate cryptic exon inclusion, both in cultured cells and in brains and spinal cords from patients with these conditions. Our findings, which demonstrate a genetic link between loss of nuclear TDP-43 function and disease, reveal the mechanism by which UNC13A variants exacerbate the effects of decreased TDP-43 function. They further provide a promising therapeutic target for TDP-43 proteinopathies. MAIN Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are devastating adult-onset neurodegenerative disorders with shared genetic causes and common pathological aggregates6. Genome-wide association studies (GWAS) have repeatedly demonstrated a shared risk locus for ALS and FTD in the crucial synaptic gene UNC13A, although the mechanism underlying this association has remained unknown1–3. ALS and FTD are pathologically defined by cytoplasmic aggregation and nuclear depletion of TAR DNA-binding protein 43 (TDP-43) in more than 97% of ALS cases and 45% of FTD cases4,5 (frontotemporal lobar degeneration (FTLD) due to TDP-43 proteinopathy (FTLD-TDP)). TDP-43 is an RNA-binding protein (RBP) that resides primarily in the nucleus and has key regulatory roles in RNA metabolism, including as a splicing repressor. Upon loss of nuclear TDP-43—an early pathological feature in TDP-43-associated ALS (ALS-TDP) and FTLD-TDP—non-conserved intronic sequences are de-repressed and erroneously included in mature RNAs. These events are referred to as cryptic exons (CEs) and often lead to premature stop codons and transcript degradation, or premature polyadenylation7. One such CE occurs in the stathmin 2 (STMN2) transcript8,9. This STMN2 CE is selectively expressed in affected tissue, and its level correlates with TDP-43 phosphorylation, enabling it to serve as a functional readout for TDP-43 proteinopathy8–10. However, a link between CEs and disease risk has not yet been established. Here we report the presence of a CE in UNC13A, which is present at high levels in neurons from patients with ALS and FTLD-TDP. This CE promotes nonsense-mediated decay (NMD) and UNC13A transcript and protein loss. Notably, intronic risk-associated single nucleotide polymorphisms (SNPs) for ALS and FTD in UNC13A promote increased inclusion of this CE. Collectively, our findings reveal the molecular mechanism behind one of the top GWAS hits for ALS and FTD and provide a promising new therapeutic target for TDP-43 proteinopathies. UNC13A CRYPTIC EXON PRODUCTION ON TDP-43 KNOCKDOWN To identify novel CEs promoted by TDP-43 depletion, we performed RNA sequencing (RNA-seq) on human induced pluripotent stem (iPS) cell-derived cortical-like i3Neurons, in which we reduced TDP-43 expression using CRISPR inhibition11–13 (CRISPRi). Differential splicing and expression analyses identified 179 CEs, including several that have been reported previously, in genes including AGRN, RAP1GAP, PFKP and STMN27,8,14 (Fig. 1a, Supplementary Data 1, 2). We examined splicing, expression, ALS GWAS15 risk genes and diagnostic panel genes for ALS and FTD16. Of the 179 CE-harbouring genes, only the synaptic gene UNC13A was also an ALS–FTD risk gene (Fig. 1b, c, Supplementary Table 1). UNC13A polymorphisms modify both disease risk and progression in ALS and FTLD-TDP1–3,15,17–19, suggesting a potential functional relationship between TDP-43, UNC13A and disease risk. Inspection of UNC13A splicing revealed the presence of a CE, occurring in two forms distinguishable by their size, between exons 20 and 21 after TDP-43 knockdown (Fig. 1b), and increased intron retention between exons 31 and 32 (Extended Data Fig. 1a). One ALS-TDP and FTLD-TDP risk SNP—rs1297319215—lies 16 bp inside the CE (hereafter referred to as the CE SNP). Another SNP—rs126089321—is located 534 bp downstream of the donor splice site of the CE within the same intron (hereafter referred to as the intronic SNP) (Fig. 1c). There are five polymorphisms associated with ALS risk in UNC13A15. All are in high linkage disequilibrium with both the CE and intronic SNPs in European populations, with an allele frequency of 0.3423 and 0.3651, respectively20 (Fig. 1d). The proximity of the disease-associated SNPs to the UNC13A CE suggests that the SNPs may influence UNC13A splicing. Of note, we also observed robust mis-splicing in UNC13B, which encodes another member of the UNC13 synaptic protein family (Fig. 1e, f). TDP-43 knockdown led to the inclusion of an annotated frame-shift-inducing exon between exons 10 and 11 in UNC13B, hereafter referred to as the UNC13B frameshift exon (FSE), and increased intron retention between exon 21 and 22 (Fig. 1e, f, Extended Data Fig. 1b).Fig. 1TDP-43 depletion in neurons leads to altered splicing in synaptic genes UNC13A and UNC13B.a, Differential splicing analysis by MAJIQ33 in control (n = 4) and CRISPRi TDP-43 depleted (KD) (n = 3) iPS cell-derived cortical-like i3Neurons. Each point denotes a splice junction. b, Representative sashimi plots showing cryptic exon (CE) inclusion between exons 20 and 21 of UNC13A upon TDP-43 knockdown. c, f, Schematics showing intron retention (IR) (orange; bottom), TDP-43 binding region22(green), and two ALS- and FTLD-associated SNPs (red) in UNC13A (c) and UNC13B (f). d, LocusZoom plot of the UNC13A locus in the most recent ALS GWAS15; the dashed line indicates the risk threshold used in that study. Lead SNP rs12973192 is plotted as a purple diamond, other SNPs are coloured by linkage disequilibrium (LD) with rs12973192 in European individuals from 1000 Genomes. Ref. var., reference variant. e, Representative sashimi plot of UNC13B showing inclusion of the FSE upon TDP-43 knockdown. g, BaseScope detection of UNC13A CE (white puncta) in control (top) and TDP-43-knockdown (bottom) i3Neurons co-stained for TDP-43 (green), neuronal processes (stained for TUBB3, pink) and nuclei (blue). Scale bar, 5 μm. h, Quantification of RT–PCR products using iPS cell-derived neurons made from an independent iPS cell line, NCRM5, with a non-targeting control short guide RNA (sgRNA) (sgTARDBP−), an intermediate TDP-43 knockdown (sgTARDBP+) or stronger TDP-43 knockdown (sgTARDBP++). Data are mean ± s.e.m. sgControl, n = 6; sgTARDBP+, n = 5; sgTARDBP++, n = 6; one-way ANOVA with multiple comparisons. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. i, Schematic of nanopore long reads quantified in j, Extended Data Figs. 2d, e, 5e, f. j, Percentage of targeted UNC13A long reads with TDP-43-regulated splice events that contain CE, intron retention or both in TDP-43-knockdown SH-SY5Y cells.Source data We validated the UNC13A CE in i3Neurons by in situ hybridization, which showed a primarily nuclear localization and occurred predominantly in TDP-43-knockdown neurons (Fig. 1g, Extended Data Fig. 1c). To confirm the CE was not restricted to neurons derived from a single iPS cell line, we performed TDP-43 knockdown in independent i3Neurons using two different guides leading to different levels of TDP-43 knockdown (Extended Data Fig. 1d, e). CE expression was restricted to cells with TDP-43 knockdown in both lines, and correlated with the level of TDP-43 knockdown (Fig. 1h, Extended Data

Read the complete text